As the accumulation of BCAA and its metabolites in the blood reflects mitochondrial metabolism in the muscles and WAT in the case of obesity, the administration of Nrf2 inducers might provide a potential preventive intervention strategy against IR and T2D. This evidence concerns the gene NFE2L2 and obesity disorder.